Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ondansetron Hydrochloride Orally Disintegrating Tablets

Approval Number

国药准字H20090059

Company北京双吉制药有限公司

Registration Date

July 22, 2024

Drug Information

Generic Name

盐酸昂丹司琼口腔崩解片

Dosage Form

片剂

Strength

4mg(以昂丹司琼计)

Drug Type

化学药品

Registration Date

July 22, 2024

Company Information

Applicant Company

Company Name北京双吉制药有限公司

Company Address

北京市门头沟区永定镇冯村西宝林寺

Manufacturing Company

Company Name北京双吉制药有限公司

Company Address

北京市门头沟区永定镇冯村西宝林寺

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy